Time-varying impact of established prognostic factors in resected pancreatic ductal adenocarcinoma

The impact of prognostic factors in resected PDAC across NAT and US patients is time-varying. Our results suggest that aggressive disease drives early mortality but, after NAT, tumor-biological factors lose prognostic importance to frailty and comorbidities over time.

Authors

Institutions

Publication Details

Journal
JNCI Journal of the National Cancer Institute
Published
2025-07-18
DOI
https://doi.org/10.1093/jnci/djaf196
Citations
1
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
1.05

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Time-varying impact of established prognostic factors in resected pancreatic ductal adenocarcinoma

Casper H.J. van Eijck, Greg D. Sacks, Hjalmar C. van Santvoort, Marc G. Besselink et al.
1 citations
JNCI Journal of the National Cancer Institute
Pancreatic and Hepatic Oncology Research
1.05
article

Time-varying impact of established prognostic factors in resected pancreatic ductal adenocarcinoma

Casper H.J. van Eijck, Greg D. Sacks, Hjalmar C. van Santvoort, Marc G. Besselink, Maarten W. Nijkamp, J. Sven D. Mieog, Kelly J. Lafaro, Bas Groot Koerkamp, Asad Saulat Fatimi, Fabio Bagante, Ingmar F. Rompen, Olivier R. Busch, Richard A. Burkhart, Gijs A. Patijn, Thomas F. Stoop, Joseph R. Habib, Brady A. Campbell, Martijn W.J. Stommel, Geert Kazemier, Marcel den Dulk, Daan J. Lips, Omar Mahmud, Erwin van der Harst, Lois A. Daamen, I Quintus Molenaar, Ignace H. J. T. de Hingh, Eric R. Manusama, Nabeela Mughal, D. Brock Hewitt, Thijs J. Schouten, Freek Daams, P. Andel, Ammar A. Javed, Iris W.J.M. van Goor, Jin He, William R. Burns, Christopher L. Wolfgang, Joost M. Klaase, Sebastiaan Festen, Jan H. Wijsman
article en
1 citations

Abstract

The impact of prognostic factors in resected PDAC across NAT and US patients is time-varying. Our results suggest that aggressive disease drives early mortality but, after NAT, tumor-biological factors lose prognostic importance to frailty and comorbidities over time.

JNCI Journal of the National Cancer InstituteVol. 117(12)
University Medical Center Groningen (NL), Johns Hopkins University (US), Radboud University Nijmegen (NL), Heidelberg University (DE), Johns Hopkins Medicine (US), Leiden University Medical Center (NL), Maastricht University Medical Centre (NL), Catharina Ziekenhuis (NL), Medisch Spectrum Twente (NL), Erasmus MC (NL), University Hospital Heidelberg (DE), Medisch Centrum Leeuwarden (NL), University Medical Center (US), Radboud University Medical Center (NL), Maastricht University (NL), NYU Langone Health (US), St. Antonius Ziekenhuis (NL), OLVG (NL), Amphia Ziekenhuis (NL), Maasstad Ziekenhuis (NL), Radboud Institute for Molecular Life Sciences (NL), Cancer Genomics Centre (NL), Aga Khan University (TZ), Isala (NL), Amsterdam University Medical Centers (NL), Cancer Center Amsterdam (NL), New York University (US), Vrije Universiteit Amsterdam (NL), University of Amsterdam (NL), Erasmus University Rotterdam (NL)
Herb Kosten Foundation
Openalex Percentile: Top 18%
Pancreatic and Hepatic Oncology Research
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.